Therapeutic and Specialty Centers of Excellence offer scientific expertise, therapeutic insights and clinical trial experience to expedite new therapies for patients.
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
IQVIA Technologies helps life sciences accelerate innovation to make a greater impact on human health. Our transformative technologies harness intelligence, integrate industry leading data and analytics, and use advanced AI/ML capabilities to unleash business potential faster.
At IQVIA our foundation is built on innovation. We are committed to finding new and smarter approaches to solving customer challenges. Explore some of the latest ways we can help drive your results.
Therapeutic and Specialty Centers of Excellence offer scientific expertise, therapeutic insights and clinical trial experience to expedite new therapies for patients.
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
IQVIA Technologies helps life sciences accelerate innovation to make a greater impact on human health. Our transformative technologies harness intelligence, integrate industry leading data and analytics, and use advanced AI/ML capabilities to unleash business potential faster.
At IQVIA our foundation is built on innovation. We are committed to finding new and smarter approaches to solving customer challenges. Explore some of the latest ways we can help drive your results.
Emerging Biopharma Commercial Solutions is a dedicated segment within IQVIA, partnering with EBPs to turn strategy into action through unmatched expertise, integrated data, and purpose-built teams.
“Emerging biopharma have become the engine of industry innovation,” now responsible for ~65% of novel drugs and nearly half of U.S. launches
IQVIA Institute
Asset Maximizer Commercial Success Framework
The Asset Maximizer Commercial Success Framework is a proven, end-to-end commercialization roadmap designed to help emerging biopharma (EBP) organizations navigate critical commercialization challenges and unlock the full potential of their assets. Through a structured, challenge-led approach, it strengthens value narratives, accelerates access and adoption, and enhances execution – driving sustained commercial success beyond launch.
Define and communicate a distinct value proposition through evidence-based scientific storytelling, brand messaging, and coordinated communications that set the asset apart in a competitive market.
Align evidence generation, pricing, reimbursement, and stakeholder engagement strategies to maximize market access and support long-term commercial success.
Deliver the right message to the right stakeholder at the right time through data-driven segmentation, targeted engagement, and coordinated omnichannel execution.
Combining IQVIA’s industry-leading data, Healthcare-grade AI®, and advanced analytics to uncover opportunities, optimize performance, and deliver real-time insights across the commercialization journey.
Drive efficient, scalable commercialization through disciplined execution, clear governance, and the operational rigor required to support long-term growth and success.
The Most Successful EBPs partner with IQVIA
As scientific innovation accelerates, commercialization grows more complex. With fully integrated capabilities, we tailor our approach to your asset’s journey to maximize market access, unify data and analytics, orchestrate personalized engagement to deliver true end-to-end commercial solutions with flawless execution.
Across all commercial phases, we collaborate with you to build a unified foundation rooted in data and evidence. Our team brings the experience, resources and personalized service to move faster, reduce risk and maximize asset value from launch through growth. By partnering with IQVIA, EBPs get the scale, data and credibility of a trusted partner who understands your journey to deliver what matters, at the moment it matters most.
Since 2023, we’ve partnered with over 1,200 emerging biopharma companies.
EXCELLENCE IN EXECUTION
650+
Over 650 first time launch companies supported since 2023.
TRUSTED PARTNERSHIP
100%
Measured by first year sales, 100% of the top performing EBP asset launches since 2023 have partnered with IQVIA.
Commercial Enablement for Emerging Biopharma
For Emerging Biopharma, commercial success depends on making insight-driven decisions, executing with precision, and maximizing asset value across global markets. IQVIA Emerging Biopharma (EBP) Commercial Solutions supports the full journey, from market prioritization through execution, combining deep local expertise, integrated data, and dedicated teams to deliver high-impact commercialization at scale.
For emerging biopharma organizations, IQVIA helps maximize your limited resources by providing flexible, scalable expertise across strategy, market access, patient engagement, and commercialization. By leveraging IQVIA’s deep therapeutic knowledge, real-world data, advanced analytics, and outsourced launch capabilities, emerging companies can access the talent, insights, and infrastructure needed to launch efficiently, reduce risk, and accelerate growth, without the cost and complexity of building large internal teams.
Yes. IQVIA Emerging Biopharma specializes in helping first-time launchers and small biopharma organizations navigate the complexities of commercialization. By combining dedicated emerging biopharma expertise with access to IQVIA’s global data, technology, and commercialization capabilities, IQVIA provides tailored support across launch planning, market access, patient engagement, and field execution, helping smaller organizations launch with confidence, reduce risk, and build a strong foundation for long-term growth.
Yes, supporting first-time launchers and more mature biopharma companies with global ambitions is a core focus. IQVIA combines dedicated emerging biopharma expertise with a truly global footprint, enabling execution across key markets in Europe, and beyond. With access to localized market knowledge, in-country teams, and integrated data and technology platforms, IQVIA supports every stage of launch, from strategy and market access to patient engagement and field execution. This allows smaller organizations to launch not just successfully, but globally, with the confidence, speed, and coordination needed to build a strong and scalable foundation for long-term growth.
IQVIA helps emerging biopharma organizations reduce launch risk by combining proven launch expertise, real-world data, predictive analytics, and tailored commercialization support to identify and address potential challenges before they impact performance. By aligning strategy, market access, field execution and patient engagement, IQVIA enables more informed decision-making and continuous optimization throughout the launch. This integrated approach and operational flexibility increases the likelihood of a successful product launch while ensuring investments are used effectively.
IQVIA understands the unique budget constraints of emerging biopharma companies and offers flexible, scalable engagement models designed to align with each organization's stage of growth and commercialization needs. By providing access to specialized expertise, technology, and commercialization resources on a tailored basis, IQVIA helps emerging companies invest where it matters most, optimize spending, and achieve launch objectives without the cost of building extensive internal infrastructure.
IQVIA helps organizations address commercialization gaps by providing targeted access to expertise, capabilities, and infrastructure across key areas such as market access, field deployment, analytics, medical affairs, and strategy. These solutions are tailored to specific needs and can be deployed quickly, allowing companies to move faster, operate more efficiently, and achieve their goals without adding internal complexity.
Beyond launch, IQVIA helps emerging biopharma organizations accelerate growth and optimize performance through a broad range of commercialization capabilities, including market access strategy, patient support programs, field force solutions, medical affairs, omnichannel engagement, advanced analytics, and performance optimization. As organizational needs evolve, IQVIA provides scalable expertise, technology, and operational support to help biopharma companies expand efficiently, adapt to changing market dynamics, and maximize the long-term value of their assets.
IQVIA supports emerging biopharma organizations through every stage of growth by providing flexible, scalable commercialization solutions that evolve alongside changing priorities, pipeline demands, and market expansion plans. Whether preparing for a first launch, adding new products, expanding into new geographies, or optimizing commercial operations, IQVIA can quickly adapt its local and global expertise, technology, and operational support to meet evolving needs, helping organizations stay agile, control costs, and drive sustainable growth without having to continuously build new internal capabilities.
IQVIA’s AI and advanced analytics transform complex healthcare data into actionable insights that improve decision-making. By identifying the highest-value providers, patient populations, and market opportunities, IQVIA enables more precise targeting, optimized resource allocation, and faster decision-making. These data-driven insights help emerging companies reduce uncertainty, improve commercial execution, and maximize launch performance while making the most of limited budgets and resources.
IQVIA provides comprehensive patient support services designed to optimize patient access, affordability, and the overall patient experience. These services include patient onboarding, reimbursement support, benefits verification, prior authorization assistance, affordability programs, adherence support, and patient engagement solutions. Backed by data, analytics, and patient-centric expertise, IQVIA helps ensure patients can access and remain on therapy while enabling organizations to improve outcomes, enhance the patient experience, and maximize the impact of their commercialization efforts.
IQVIA helps organizations address commercialization gaps by providing targeted access to expertise, capabilities, and infrastructure across key areas such as market access, field deployment, analytics, medical affairs, and strategy. These solutions are tailored to specific needs and can be deployed quickly, allowing companies to move faster, operate more efficiently, and achieve their goals without adding internal complexity.
.svg){kind=icon}
